Should vasopressors be started as the initial therapy in hemorrhagic shock?

Vasopressors Should NOT Be Started as Initial Therapy in Hemorrhagic Shock

Vasopressors should not be used as initial therapy in hemorrhagic shock; fluid resuscitation with crystalloids is the first-line treatment, and vasopressors may only be considered transiently when life-threatening hypotension persists despite adequate volume replacement. 1

Primary Management Strategy

Fluid Resuscitation First

• Crystalloid solutions are the recommended initial treatment for hemorrhagic shock, not vasopressors 1
• Fluid resuscitation is the first strategy to restore mean arterial pressure and systemic blood flow in hemorrhagic shock 1, 2
• The priority is controlling bleeding with simultaneous volume resuscitation to maintain adequate tissue perfusion 3

Permissive Hypotension Approach

• Target mean arterial pressure of 65 mmHg or systolic blood pressure of 80-90 mmHg in patients without traumatic brain injury until bleeding is controlled 1, 2
• This strategy avoids exacerbating hemorrhage while maintaining minimal tissue perfusion 1

The Problem with Early Vasopressor Use

Evidence Against Early Vasopressors

• Early vasopressor use in hemorrhagic shock is associated with over 80% higher mortality risk at 12 hours and over twofold higher mortality at 24 hours compared to aggressive crystalloid resuscitation 4
• Vasopressors are traditionally contraindicated in early hemorrhagic shock management due to deleterious consequences 3
• The Advanced Trauma Life Support principles do not recommend vasopressor use in this setting 3

Mechanism of Harm

• Potent vasoconstriction can worsen organ perfusion and tissue hypoxia when intravascular volume has not been restored 1, 5
• Vasopressors risk severe peripheral and visceral vasoconstriction with decreased renal perfusion, diminished blood flow, and subsequent tissue hypoxia and lactic acidosis 5
• Prolonged administration without correcting plasma volume depletion can lead to ischemic injury and, rarely, gangrene of extremities 5

Limited Role for Vasopressors

When Vasopressors May Be Considered

• Only transiently required to sustain life in the presence of life-threatening hypotension while fluid expansion is in progress and hypovolemia has not yet been corrected 1, 2
• May be used when fluid resuscitation fails to restore adequate blood pressure and tissue perfusion 1, 2
• Should not be viewed as a substitute for fluid resuscitation; the target blood pressure must be respected 1

Choice of Vasopressor (If Needed)

• Norepinephrine is the preferred vasopressor if one must be used in hemorrhagic shock 1, 2
• Vasopressin in small doses may be considered as an alternative, as animal studies suggest it produces more sustained increases in diastolic pressure with potentially better tissue perfusion than epinephrine 2, 6
• Meta-analysis of animal studies shows vasopressin and terlipressin improve survival (mortality 15% vs 63% in controls), though human clinical trial data are lacking 6

Critical Caveats

Contraindications to Permissive Hypotension

• Traumatic brain injury and spinal cord injuries require adequate perfusion pressure to ensure tissue oxygenation of the injured central nervous system 1
• Elderly patients and those with chronic arterial hypertension may not tolerate permissive hypotension 1

Importance of Withdrawal

• The importance of withdrawing vasopressors is comparable to the indication for their initiation 2
• Vasopressors should be titrated down as soon as tolerated during fluid resuscitation 2
• If plasma volumes are not corrected before discontinuing vasopressors, hypotension may recur 5

Monitoring Priorities

• Complement hemodynamic objectives with serial markers of systemic and organ perfusion: lactate, central venous oxygen saturation, urine output, and mental status 2
• Elevated lactate levels are associated with increased mortality and should guide resuscitation 2
• Target hemoglobin of 7-9 g/dL with restrictive transfusion strategy 2